Is CME Group Stock Outperforming the Dow? - Yahoo Finance
- π CME Group Inc., a Chicago-based market leader, operates futures and options contracts across interest rates, equities, FX, commodities, and energy.
- π° With a $115.2 billion market cap, CME qualifies as a large-cap stock and dominates the financial data and stock exchanges industry.
- π‘οΈ The company holds exclusive rights to trade and clear S&P futures contracts, solidifying its competitive advantage in the derivatives market.
- π Despite trading 1% below its 52-week high of $322.57 set on Feb. 25, CME stock gained 13.8% over the last three months.
- π Over the past year, shares climbed 27.9%, significantly outperforming the Dow Jones Industrials Averageβs 13.3% return and YTD gains of 1.9%.
- π Technical indicators confirm a bullish trend with the stock trading above its 50-day and 200-day moving averages since early November 2025.
- π‘ Growth is driven by broad-based activity in key asset classes including interest rates, energy, metals, agriculture, and crypto products.
- π Strategic initiatives include launching new securities clearing services, 24/7 crypto trading, and additional crypto futures while maintaining cost discipline.
- π On Feb. 4, CME reported Q4 results with adjusted EPS of $2.77 that beat analyst expectations of $2.75 and revenue of $1.7 billion vs. $1.6 billion forecasts.
- βοΈ Competitor Intercontinental Exchange (ICE) has lagged behind, recording a 1.3% YTD gain but losing 3.9% over the past 52 weeks compared to CME's gains.
- π¨βπΌ Wall Street analysts maintain a "Moderate Buy" rating on CME based on consensus from 17 covering analysts.
- π― Although trading above the mean price target of $304.27, the high-end analyst target of $340 suggests remaining upside potential of approximately 6.4%.
- CME stock has gained 13.8% over the past three months, significantly outperforming the Dow Jones Industrials Average's 3.3% gains during the same period.
- Shares of CME rose 17% on a year-to-date basis and climbed 27.9% over the past 52 weeks, while the benchmark Dow indices lagged behind with only 1.9% and 13.3% returns respectively.
- The company reported strong Q4 results where its adjusted EPS of $2.77 surpassed Wall Street expectations of $2.75, and revenue of $1.7 billion beat forecasts of $1.6 billion.
- CME holds exclusive rights to trade and clear S&P futures contracts, cementing its leadership position and granting it a solid competitive advantage in the derivatives market.
- Wall Street analysts maintain a consensus 'Moderate Buy' rating with a street-high price target of $340, suggesting a positive 6.4% upside potential from current levels.
- The company is driving innovation through new initiatives like securities clearing and the launch of additional crypto futures to attract increased retail participation.
- CME has demonstrated strong technical strength by trading above its 200-day moving average for the past year and maintaining a bullish stance above its 50-day moving average since early November.
- CME stock slipped 1% from its 52-week high of $322.57, achieved on Feb. 25.
- While the company reports a 'Moderate Buy' rating, Wall Street analysts have only 17 covers, indicating limited analyst consensus compared to larger mega-cap stocks.
- The stock currently trades above its mean price target of $304.27, suggesting significant downside risk if the consensus view corrects downward.
- CME faces competition from Intercontinental Exchange (ICE), which, while lagging in YTD performance, still holds a significant market share in the financial data and stock exchanges sector.